These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23494449)

  • 1. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
    Pham MN; Kolb H; Battelino T; Ludvigsson J; Pozzilli P; Zivehe F; Roden M; Mandrup-Poulsen T; Schloot NC;
    Diabetologia; 2013 Jun; 56(6):1356-63. PubMed ID: 23494449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.
    Pfleger C; Mortensen HB; Hansen L; Herder C; Roep BO; Hoey H; Aanstoot HJ; Kocova M; Schloot NC;
    Diabetes; 2008 Apr; 57(4):929-37. PubMed ID: 18299313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.
    Pham MN; Hawa MI; Pfleger C; Roden M; Schernthaner G; Pozzilli P; Buzzetti R; Scherbaum WA; Seissler J; Kolb H; Hunter S; Leslie RD; Schloot NC;
    Diabetologia; 2011 Jul; 54(7):1630-8. PubMed ID: 21347621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
    Strom A; Kolb H; Martin S; Herder C; Simon MC; Koenig W; Heise T; Heinemann L; Roden M; Schloot NC;
    PLoS One; 2012; 7(3):e33108. PubMed ID: 22448235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).
    Kolb H; Lückemeyer K; Heise T; Herder C; Schloot NC; Koenig W; Heinemann L; Martin S;
    PLoS One; 2013; 8(8):e72440. PubMed ID: 23991111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes.
    Overgaard AJ; Madsen JOB; Pociot F; Johannesen J; Størling J
    BMC Pediatr; 2020 Sep; 20(1):446. PubMed ID: 32967650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
    Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
    Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune mediators are closely linked in adult-onset type 1 diabetes as well as in non-diabetic subjects.
    Fleiner HF; Radtke M; Ryan L; Moen T; Grill V
    Autoimmunity; 2014 Dec; 47(8):530-7. PubMed ID: 25027869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a combined lifestyle intervention with and without protein drink on inflammation in older adults with obesity and type 2 diabetes.
    Memelink RG; Njemini R; de Bos Kuil MJJ; Wopereis S; de Vogel-van den Bosch J; Schoufour JD; Tieland M; Weijs PJM; Bautmans I
    Exp Gerontol; 2024 Jun; 190():112410. PubMed ID: 38527636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin.
    Pham MN; Kolb H; Mandrup-Poulsen T; Battelino T; Ludvigsson J; Pozzilli P; Roden M; Schloot NC;
    Diabetes Metab Res Rev; 2013 Feb; 29(2):166-70. PubMed ID: 23197433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.
    Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T
    Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.
    Li L; Shen S; Ouyang J; Hu Y; Hu L; Cui W; Zhang N; Zhuge YZ; Chen B; Xu J; Zhu D
    J Clin Endocrinol Metab; 2012 May; 97(5):1729-36. PubMed ID: 22419704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.
    Erbağci AB; Tarakçioğlu M; Coşkun Y; Sivasli E; Sibel Namiduru E
    Clin Biochem; 2001 Nov; 34(8):645-50. PubMed ID: 11849625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
    Thivolet C; Marchand L; Chikh K
    Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
    Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
    Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relation between residual β-cell function and autoimmune status in long-term type 1 diabetes patients].
    Cheng J; Zhong T; Yan X; Xie YT; He BB; Li X; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1209-1215. PubMed ID: 35462503
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.
    Kaas A; Pfleger C; Hansen L; Buschard K; Schloot NC; Roep BO; Mortensen HB;
    Clin Exp Immunol; 2010 Sep; 161(3):444-52. PubMed ID: 20529086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Marcovecchio ML; Hendriks AEJ; Delfin C; Battelino T; Danne T; Evans ML; Johannesen J; Kaur S; Knip M; Overbergh L; Pociot F; Todd JA; Van der Schueren B; Wicker LS; Peakman M; Mathieu C;
    Diabetologia; 2024 Jun; 67(6):995-1008. PubMed ID: 38517484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.
    Downes K; Marcovecchio ML; Clarke P; Cooper JD; Ferreira RC; Howson JM; Jolley J; Nutland S; Stevens HE; Walker NM; Wallace C; Dunger DB; Todd JA
    Diabetologia; 2014 Feb; 57(2):366-72. PubMed ID: 24264051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.